Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study

Details

Serval ID
serval:BIB_88A70E460106
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study
Journal
HIV Clinical Trials
Author(s)
Glass  T. R., Weber  R., Vernazza  P. L., Rickenbach  M., Furrer  H., Bernasconi  E., Cavassini  M., Hirschel  B., Battegay  M., Bucher  H. C.
ISSN
1528-4336 (Print)
Publication state
Published
Issued date
04/2007
Volume
8
Number
2
Pages
77-85
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Mar-Apr
Abstract
PURPOSE: Antiretroviral therapy (ART) may induce metabolic changes and increase the risk of coronary heart disease (CHD). Based on a health care system approach, we investigated predictors for normalization of dyslipidemia in HIV-infected individuals receiving ART. METHOD: Individuals included in the study were registered in the Swiss HIV Cohort Study (SHCS), had dyslipidemia but were not on lipid-lowering medication, were on potent ART for >or= 3 months, and had >or= 2 follow-up visits. Dyslipidemia was defined as two consecutive total cholesterol (TC) values above recommended levels. Predictors of achieving treatment goals for TC were assessed using Cox models. RESULTS: Analysis included 958 individuals with median followup of 2.3 years (IQR 1.2-4.0). 454 patients (47.4%) achieved TC treatment goals. In adjusted analyses, variables significantly associated with a lower hazard of reaching TC treatment goals were as follows: older age (compared to 18-37 year olds: hazard ratio [HR] 0.62 for 45-52 year olds, 95% CI 0.47-0.82; HR 0.40 for 53-85, 95% CI 0.29-0.54), diabetes (HR 0.39, 95% CI 0.26-0.59), history of coronary heart disease (HR 0.27, 95% CI 0.10-0.71), higher baseline TC (HR 0.78, 95% CI 0.71-0.85), baseline triple nucleoside regimen (HR 0.12 compared to PI-only regimen, 95% CI 0.07-0.21), longer time on PI-only regimen (HR 0.39, 95% CI 0.33-0.46), longer time on NNRTI only regimen (HR 0.35, 95% CI 0.29-0.43), and longer time on PI/NNRTI regimen (HR 0.34, 95% CI 0.26-0.43). Switching ART regimen when viral load was undetectable was associated with a higher hazard of reaching TC treatment goals (HR 1.48, 95% CI 1.14-1.91). CONCLUSION: In SHCS participants on ART, several ART-related and not ART-related epidemiological factors were associated with insufficient control of dyslipidemia. Control of dyslipidemia in ART recipients must be further improved.
Keywords
Adolescent Adult Age Factors Aged Aged, 80 and over *Antiretroviral Therapy, Highly Active Cohort Studies Dyslipidemias/*drug therapy/*epidemiology Female HIV Infections/*complications/*drug therapy Humans Male Middle Aged Prospective Studies Risk Factors Time Factors
Pubmed
Web of science
Create date
29/01/2008 8:52
Last modification date
20/08/2019 14:47
Usage data